TSG-6 as a biomarker to predict efficacy of human mesenchymal stem/progenitor cells (hMSCs) in modulating sterile inflammation in vivo-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

TSG-6 as a biomarker to predict efficacy of human mesenchymal stem/progenitor cells (hMSCs) in modulating sterile inflammation in vivo

Published:2014-11-10 Issue:47 Volume:111 Page:16766-16771
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proc Natl Acad Sci USA

Author:

Lee Ryang Hwa,Yu Ji Min,Foskett Andrea M.,Peltier Grant,Reneau John C.,Bazhanov Nikolay,Oh Joo Youn,Prockop Darwin J.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference37 articles.

1. Stem cell therapy market

2. Mesenchymal Stromal Cells: New Directions

3. Mesenchymal Stem/Stromal Cells (MSCs): Role as Guardians of Inflammation

4. Donor variation in the growth properties and osteogenic potential of human marrow stromal cells

5. Dissimilar characteristics of umbilical cord mesenchymal stem cells from donors of different ages

Cited by 165 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biopotency and surrogate assays to validate the immunomodulatory potency of extracellular vesicles derived from mesenchymal stem/stromal cells for the treatment of experimental autoimmune uveitis;Journal of Extracellular Vesicles;2024-08

2. TSG-6 Is Involved in Fibrous Structural Remodeling after the Injection of Adipose-derived Stem Cells;Plastic and Reconstructive Surgery - Global Open;2024-07

3. Unveiling heterogeneity in MSCs: exploring marker-based strategies for defining MSC subpopulations;Journal of Translational Medicine;2024-05-15

4. Scalable manufacture of therapeutic mesenchymal stromal cell products on customizable microcarriers in vertical wheel bioreactors that improve direct visualization, product harvest, and cost;Cytotherapy;2024-04

5. Improved therapeutic consistency and efficacy of CD317+ MSCs through stabilizing TSG6 by PTX3;Stem Cell Research & Therapy;2024-03-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3